The ADRD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADRD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ADRD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ADRD Detailed Price Forecast - CNN Money||View ADRD Detailed Summary - Google Finance|
|View ADRD Detailed Summary - Yahoo! Finance||View ADRD Stock Research & Analysis - Zacks.com|
|View ADRD Trends & Analysis - Trade-Ideas||View ADRD Major Holders - Barrons|
|View ADRD Call Transcripts - NASDAQ||View ADRD Breaking News & Analysis - Seeking Alpha|
|View ADRD Annual Report - CompanySpotlight.com||View ADRD OTC Short Report - OTCShortReport.com|
|View ADRD Fundamentals - TradeKing||View ADRD SEC Filings - Bar Chart|
|View Historical Prices for ADRD - The WSJ||View Performance/Total Return for ADRD - Morningstar|
|View the Analyst Estimates for ADRD - MarketWatch||View the Earnings History for ADRD - CNBC|
|View the ADRD Earnings - StockMarketWatch||View ADRD Buy or Sell Recommendations - MacroAxis|
|View the ADRD Bullish Patterns - American Bulls||View ADRD Short Pain Metrics - ShortPainBot.com|
|View ADRD Stock Mentions - StockTwits||View ADRD Stock Mentions - PennyStockTweets|
|View ADRD Stock Mentions - Twitter||View ADRD Investment Forum News - Investor Hub|
|View ADRD Stock Mentions - Yahoo! Message Board||View ADRD Stock Mentions - Seeking Alpha|
|View Insider Transactions for ADRD - SECform4.com||View Insider Transactions for ADRD - Insider Cow|
|View ADRD Major Holdings Summary - CNBC||View Insider Disclosure for ADRD - OTC Markets|
|View Insider Transactions for ADRD - Yahoo! Finance||View Institutional Holdings for ADRD - NASDAQ|
|View ADRD Stock Insight & Charts - FinViz.com||View ADRD Investment Charts - StockCharts.com|
|View ADRD Stock Overview & Charts - BarChart||View ADRD User Generated Charts - Trading View|
Novartis’s Key Developments in August
Posted on Thursday August 30, 2018
As we’ve already seen, Novartis (NVS) reported a 7% growth YoY (year-over-year) in revenues to ~$13.16 billion during Q2 2018.
Novartis’s Innovative Medicines Business in Q2 2018
Posted on Wednesday August 29, 2018
As we’ve already seen, Novartis’s (NVS) Innovative Medicines business includes prescription products from two business units: Novartis Pharmaceuticals and Novartis Oncology. Innovative Medicines contributed ~67.4% of Novartis’s total revenues in Q2 2018, a 10% growth YoY (year-over-year) to $8.9 billion.
Analysts’ Recommendations for GlaxoSmithKline Stock
Posted on Wednesday August 15, 2018
This year, analysts expect GlaxoSmithKline’s (GSK) revenue to grow 0.4% YoY (year-over-year) to ~30.3 billion British pounds from ~30.2 billion pounds, and its income margin to narrow YoY to 17.9% from 18.1%. They expect it to report EPS of 110.75 pence.
Analyzing GlaxoSmithKline’s Revenue Trends
Posted on Monday August 13, 2018
In the second quarter, GlaxoSmithKline’s (GSK) revenue was nearly flat YoY (year-over-year) at 7.3 billion British pounds, reflecting 4% growth at constant exchange rates offset by a 4% impact by foreign exchange. The pound strengthened, weakening GSK’s revenue. The chart below shows GlaxoSmithKline’s revenue since the first quarter of 2017.